You are here

Article info

Article menu
Download PDFPDF
Article
Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update

Authors

  • Mark W Davis aClinical Development, Amgen Inc, Thousand Oaks, One Amgen Center Drive, Mail Stop 24–1-B, Thousand Oaks, California, 91320–1789, USA, bDepartment of Pharmacology, Amgen Inc, cBolder Path Inc, University of Colorado, dResearch and Development, Amgen Inc PubMed articlesGoogle scholar articles
  • Ulrich Feige aClinical Development, Amgen Inc, Thousand Oaks, One Amgen Center Drive, Mail Stop 24–1-B, Thousand Oaks, California, 91320–1789, USA, bDepartment of Pharmacology, Amgen Inc, cBolder Path Inc, University of Colorado, dResearch and Development, Amgen Inc PubMed articlesGoogle scholar articles
  • Alison M Bendele aClinical Development, Amgen Inc, Thousand Oaks, One Amgen Center Drive, Mail Stop 24–1-B, Thousand Oaks, California, 91320–1789, USA, bDepartment of Pharmacology, Amgen Inc, cBolder Path Inc, University of Colorado, dResearch and Development, Amgen Inc PubMed articlesGoogle scholar articles
  • Steven W Martin aClinical Development, Amgen Inc, Thousand Oaks, One Amgen Center Drive, Mail Stop 24–1-B, Thousand Oaks, California, 91320–1789, USA, bDepartment of Pharmacology, Amgen Inc, cBolder Path Inc, University of Colorado, dResearch and Development, Amgen Inc PubMed articlesGoogle scholar articles
  • Carl K Edwards aClinical Development, Amgen Inc, Thousand Oaks, One Amgen Center Drive, Mail Stop 24–1-B, Thousand Oaks, California, 91320–1789, USA, bDepartment of Pharmacology, Amgen Inc, cBolder Path Inc, University of Colorado, dResearch and Development, Amgen Inc PubMed articlesGoogle scholar articles
  1. Mark W Davis (markd{at}amgen.com)
View Full Text

Citation

Davis MW, Feige U, Bendele AM, et al
Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update
Annals of the Rheumatic Diseases 2000;59:i41-i43.

Publication history

  • First published November 1, 2000.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases